Abstract-The
Reports
have been published on the analgesic response to opioids (1, 2) and hyperalgesic reactions to opioid antagonists (3) in different strains of mice. However, the stereoselectivity of opioid antagonists on nociceptive reactions in different strains of mice has not yet been reported. Therefore, the present experiments were undertaken to elucidate the stereoselectivity of a diastereo isomeric pair of N-tetrahydrofurfurylnor morphones, Mr2096, an agonist, and Mr2097, an antagonist (4) , and diprenorphine, an oripavine antagonist, on the jumping response using the hot plate test. Additionally the involvement of kappa receptors in pain control was also examined by using a kappa agonist, (-)bremazocine (5), and a selective kappa antagonist, Mr2266 (6), in these strains of mice.
Five different strains of mice (Swiss, CXBK, C57BL, CXBH and CBA; all male; 4-6 weeks old; 20-28 g) were obtained from the Laboratory Animal Center, National Uni versity of Singapore and were allowed to adapt to the new environment for at least one week. The jumping latencies were measured using the hot plate technique previously described (3, 7) . The apparatus consisted of a hot plate maintained at 55°C on which a restraining glass cylinder (height, 17 cm; diameter, 13 cm) was placed. The " cut-off" time was 120 sec. The jumping response was the end point and the jumping latencies were recorded by an experienced observer who was "blind" to treatment schedules. The mice were exposed to the hot plate only once. Control groups received the solvent at the appropriate time. All the tests were conducted between 14:00 hr and 18:00 hr. Groups of 20 mice were used for each treatment. The solutions were admin istered in a volume of 0.5 ml/20 g. Statistical significance of the data was evaluated by Student's t-test.
The effects of Mr2096, Mr2097 and diprenorphine on the jumping latencies of Swiss, CXBK, C57BL, CXBH and CBA strains of mice are shown in Fig. 1 . In Swiss, CXBK and C57BL strains, low doses of Mr2096 (0.3, 1 mg/kg) produced prolon gation of jumping latencies, and higher doses (3, 10 mg/kg) did not produce any significant effect; the falling-off of the analgesic effect of Mr2096 in these strains of mice might be related to its mixed agonist-antagonist properties (4). In the slow responding CXBH and CBA strains, Mr2096 over a wide range of doses (0.3, 1, 3 and 10 mg/kg) produced significant analgesia as measured by the prolongation of jumping latencies. However, in these strains, the analgesic effect of Mr2096 regressed for 3 and 10 mg/kg. induced by diprenorphine might be mediated by both mu and kappa receptors as it is regarded as a universal antagonist at both sites.
The involvement of kappa opioid receptors in the regulation of nociception was also examined using a kappa agonist,
bremazocine, and a selective kappa an tagonist, Mr2266. (-) Bremazocine
(1 mg/ kg) and Mr2266
(1 mg/kg) produced hyperalgesia in the Swiss and CBA strains but not in others, a finding which was consistent with an earlier report (8).
The present study showed, firstly, that Mr2096 and Mr2097 respectively produced analgesia and hyperalgesia in Swiss, CXBK, C57BL, CXBH and CBA strains of mice. 
